Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus Prophylaxis”

112 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 112 results

Post-approval studies (Phase 4)UnknownNCT05914701
What this trial is testing

Secondary Prophylaxis of CMV Infection Using Letermovir After HID-HSCT

Who this might be right for
To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
Institute of Hematology & Blood Diseases Hospital, China 31
Large-scale testing (Phase 3)Study completedNCT04693637
What this trial is testing

Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Adenovirus InfectionBK Virus InfectionCytomegalovirus Infections+3 more
AlloVir 26
Not applicableStudy completedNCT00566072
What this trial is testing

The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial

Who this might be right for
Cytomegalovirus Infections
University Hospital, Ghent 21
Testing effectiveness (Phase 2)Study completedNCT01252017
What this trial is testing

Nilotinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Patients Who Have Received Allo-HSCT
National Taiwan University Hospital 36
Large-scale testing (Phase 3)Study completedNCT00881517
What this trial is testing

Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection

Who this might be right for
Cytomegalovirus Infection
Fondazione IRCCS Policlinico San Matteo di Pavia 124
Testing effectiveness (Phase 2)UnknownNCT05432778
What this trial is testing

Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients

Who this might be right for
CMV Viremia
University Medical Centre Ljubljana 90
Not applicableLooking for participantsNCT06494033
What this trial is testing

Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients

Who this might be right for
Lung Diseases
University of Miami 100
Large-scale testing (Phase 3)Study completedNCT00411645
What this trial is testing

Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients

Who this might be right for
Cytomegalovirus Infections
Shire 681
Post-approval studies (Phase 4)Looking for participantsNCT06958796
What this trial is testing

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

Who this might be right for
CytomegalovirusOrgan TransplantKidney Transplant; Complications+2 more
Camille N. Kotton, MD 80
Testing effectiveness (Phase 2)UnknownNCT05969743
What this trial is testing

Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease

Who this might be right for
Graft-versus-host-diseaseCMV
Rabin Medical Center 42
Large-scale testing (Phase 3)Study completedNCT03930615
What this trial is testing

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Who this might be right for
Cytomegalovirus Infection
Merck Sharp & Dohme LLC 220
Large-scale testing (Phase 3)Study completedNCT01769170
What this trial is testing

The Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients

Who this might be right for
CMV
Jazz Pharmaceuticals 452
Large-scale testing (Phase 3)Ended earlyNCT02439970
What this trial is testing

Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease

Who this might be right for
Cytomegalovirus Disease
Jazz Pharmaceuticals 5
Early research (Phase 1)UnknownNCT03576014
What this trial is testing

Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

Who this might be right for
Cytomegalovirus InfectionsPreventation of Cytomegalovirus ReactivationBK Virus Infection+1 more
SL VAXiGEN 18
Testing effectiveness (Phase 2)Study completedNCT02227641
What this trial is testing

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Who this might be right for
Patients Undergoing Allogeneic Stem Cell Transplantation
University of Erlangen-Nürnberg Medical School 50
Not applicableNot Yet RecruitingNCT06814301
What this trial is testing

Impact of CMV-Specific Immune Reconstitution at the End of Letermovir Prophylaxis on the Development of Late Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients (INMUNOEND)

Who this might be right for
Cytomegalovirus Cell Mediated ImmunityStem Cell Transplantation, Hematopoietic
Maimónides Biomedical Research Institute of Córdoba 123
Large-scale testing (Phase 3)Study completedNCT00497796
What this trial is testing

Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients

Who this might be right for
Cytomegalovirus Infections
Shire 307
Testing effectiveness (Phase 2)Study completedNCT01503918
What this trial is testing

Cytomegalovirus Control in Critical Care

Who this might be right for
Critical Illness
University Hospital Birmingham NHS Foundation Trust 124
Testing effectiveness (Phase 2)Looking for participantsNCT06575374
What this trial is testing

Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell

Who this might be right for
Cell Therapy
M.D. Anderson Cancer Center 36
Large-scale testing (Phase 3)Study completedNCT00001038
What this trial is testing

Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Next Page